Clinical and laboratory parameters associated with febrile seizure recurrence within the first 24 h: a ten-year cohort study
- PMID: 38500593
- PMCID: PMC10944896
- DOI: 10.3389/fped.2024.1373848
Clinical and laboratory parameters associated with febrile seizure recurrence within the first 24 h: a ten-year cohort study
Abstract
Introduction: We assessed clinical and laboratory parameters associated with early recurrence of febrile seizure in patients presenting at the Emergency Department with a first episode.
Methods: Case series of patients admitted to the emergency department with the first episode of febrile seizure for ten consecutive years. Exclusion criteria were focal features and prolonged duration (>15 min).
Results: We included 693 patients, 284 (41%) female. Median age of 20 (IQR 15-27) months. Fifty-two (8%) patients had a recurrence within 24 h. At univariate analysis, patients with recurrent seizures had higher use of antipyretics (88% vs. 74%, P = 0.03, OR 2.6, 95% CI: 1.1-7.7), higher median maximal body temperature (39.3 °C, IQR 38.9-39.9, vs. 38.9, IQR 38.4-39.3, P < 0.001, OR 2.3, 95% CI: 1.5-2.6) and presented with a lower proportion of respiratory tract infections (54% vs. 70%, P = 0.02) compared to patients without recurrence. A maximal body temperature equal to or higher than 39 °C was associated with a higher recurrence (11% vs. 4%, P < 0.001, OR 2.9, 95% CI: 1.6-5.6). Hyponatremia was not associated with a risk of recurrence. The multivariate analysis confirmed a direct association with body temperature (OR 2.3, 95% CI: 1.5-3.7, P < 0.001), and an inverse association with respiratory tract infections (OR 0.4, 95% CI: 0.2-0.9, P = 0.01), while antipyretic use was not correlated (OR 1.9, 95% CI: 0.8-5.2, P = 0.2).
Conclusions: High body temperature and respiratory tract infections were (directly and inversely) associated with recurrences. Consideration of these conditions might help for anticipating the probability of recurrence.
Keywords: children; febrile seizure; fever; recurrence; risk factors.
© 2024 Castellazzi, La Vecchia, Scali, Agostoni, Di Pietro and Milani.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Randomized, controlled trial of ibuprofen syrup administered during febrile illnesses to prevent febrile seizure recurrences.Pediatrics. 1998 Nov;102(5):E51. doi: 10.1542/peds.102.5.e51. Pediatrics. 1998. PMID: 9794981 Clinical Trial.
-
Temperature, age, and recurrence of febrile seizure.Arch Pediatr Adolesc Med. 1998 Dec;152(12):1170-5. doi: 10.1001/archpedi.152.12.1170. Arch Pediatr Adolesc Med. 1998. PMID: 9856424 Clinical Trial.
-
Prophylactic drug management for febrile seizures in children.Cochrane Database Syst Rev. 2021 Jun 16;6(6):CD003031. doi: 10.1002/14651858.CD003031.pub4. Cochrane Database Syst Rev. 2021. PMID: 34131913 Free PMC article.
-
A prospective study of recurrent febrile seizures.N Engl J Med. 1992 Oct 15;327(16):1122-7. doi: 10.1056/NEJM199210153271603. N Engl J Med. 1992. PMID: 1528207
-
Prophylactic drug management for febrile seizures in children (Review).Evid Based Child Health. 2013 Jul;8(4):1376-485. doi: 10.1002/ebch.1921. Evid Based Child Health. 2013. PMID: 23877946 Review.